Ronovo Surgical

Executive Summary

Ronovo Surgical is a Chinese medical device company developing the Carina™ modular robotic surgery platform, designed to democratize minimally invasive surgery through true modularity, mobile patient carts, and cost-effective configurations. Founded in 2020 and now at the commercial stage with 50-200 employees, the company targets multiple surgical specialties and has established a presence in Shanghai. Its platform aims to address key barriers to robotic surgery adoption—high cost and inflexible room setups—by enabling hospitals to configure systems flexibly. With China's rapidly expanding minimally invasive surgery market, Ronovo is well-positioned to capture significant share, though it faces competition from established players like Intuitive Surgical. The company's success hinges on regulatory approvals, clinical evidence, and commercial execution.

Upcoming Catalysts (preview)

• Q3 2026CE Mark approval for Carina robotic system in Europe60% success
• Q4 2026Strategic partnership with a top-tier Chinese hospital group75% success
• Q2 2026Publication of clinical outcomes from initial cases85% success